News & Updates

Hot snare polypectomy (HSP) tends to result in higher complete resection and lower recurrence rates, but a greater incidence of adverse events, compared with cold snare polypectomy (CSP), according to a study.

Older and more fragile patients who present with severe complications associated with acute biliary pancreatitis (ABP) may not be the best candidates for early cholecystectomy, real-life data from the MANCTRA-1* study.

In patients with locally advanced pancreatic cancer, treatment with intra-arterial gemcitabine leads to better survival and safety outcomes compared with standard-of-care therapy with intravenous gemcitabine/nab-paclitaxel, according to the first interim analysis of the phase III TIGeR-PaC trial presented at ESMO GI 2023.

A recent study comparing two commercially available single-use disposable duodenoscopes (SDD), Exalt and aScope Duodeno, reports comparable safety and efficacy.

Topical diclofenac gel significantly reduced the incidence of hand-foot syndrome (HFS) in patients with gastrointestinal (GI) cancer receiving capecitabine, according to findings from the exploratory subgroup analysis of the D-ToRCH* trial.

In the treatment of patients with esophageal cancer, proton-based radiotherapy appears to yield better safety and efficacy outcomes including organs at risk (OARs) doses, toxicity, and prognosis when compared with photon therapy, according to a meta-analysis.

The use of proton pump inhibitors (PPIs) appears to pose heightened risks of serious infections in young children, according to a study.

In patients with localized colon cancer, a low Immunoscore is indicative of poorer clinical outcomes, particularly disease-free and overall survival, suggest the results of a Philippines study presented at the recent ESMO GI 2023.